CC BY-NC-ND 4.0 · Revista Argentina de Radiología / Argentinian Journal of Radiology 2018; 82(02): 064-071
DOI: 10.1055/s-0038-1641159
Review Article | Revisión de Tema
Sociedad Argentina de Radiología. Publicado por Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Elastografía hepática y otras secuencias avanzadas de RM (RM multiparamétrica)

Hepatic Elastography and Other Advanced MRI Sequences (Multiparametric MRI)
Andrés Domínguez
1   Fundación Escuela de Medicina Nuclear (FUESMEN), Ciudad de Mendoza, Mendoza, Argentina
,
Maximiliano Noceti
1   Fundación Escuela de Medicina Nuclear (FUESMEN), Ciudad de Mendoza, Mendoza, Argentina
,
Daniel Fino
1   Fundación Escuela de Medicina Nuclear (FUESMEN), Ciudad de Mendoza, Mendoza, Argentina
,
Pablo Ariza
1   Fundación Escuela de Medicina Nuclear (FUESMEN), Ciudad de Mendoza, Mendoza, Argentina
› Author Affiliations
Further Information

Publication History

11 August 2017

19 February 2018

Publication Date:
14 May 2018 (online)

Resumen

La fibrosis es un destino donde convergen variados trastornos hepáticos. Al tratarse de un proceso dinámico y reversible, su detección temprana y una intervención terapéutica oportuna, pueden frenar su progresión. La elastografía por resonancia magnética (ERM), es un método no invasivo con notable eficacia para la valoración del grado de fibrosis hepática. La tendencia actual es combinar esa técnica con secuencias de cuantificación de lípidos y hierro, lo cual permite un abordaje multiparamétrico de los trastornos difusos del hígado.

Abstract

Fibrosis is a common destination where multiple liver disorders converge. Due to its dynamic and reversible process, an early detection and timely therapeutic intervention can interrupt its progression. Magnetic Resonance Elastography (MRE) is a non-invasive method with remarkable efficacy for assessing the degree of liver fibrosis. The current trend is to combine this technique with lipid and iron quantification sequences, which allows a multiparametric approach to diffuse liver disorders.

 
  • Bibliografía

  • 1 Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J 2008; 411 (01) 1-18
  • 2 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115 (02) 209-218
  • 3 Younossi ZM, Stepanova M, Rafiq N. , et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011; 53 (06) 1874-1882
  • 4 Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2 (02) 165-173
  • 5 Huwart L, Sempoux C, Salameh N. , et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 2007; 245 (02) 458-466
  • 6 Castera L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol 2011; 25 (02) 291-303
  • 7 Fassio E, Mazzolini G, Villamil A, Gadano A. Consenso argentino de hepatocarcinoma. 2015. Disponible en: http://www.aaeeh.org.ar/consensos-y-guias/ . (consultado Feb 2018)
  • 8 Younossi ZM, Stepanova M, Afendy M. , et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9 (06) 524-530.e1 , quiz e60
  • 9 Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 1995; 269 (5232): 1854-1857
  • 10 Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: clinical applications. J Comput Assist Tomogr 2013; 37 (06) 887-896
  • 11 Bedossa P, Poynard T. ; The METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24 (02) 289-293
  • 12 Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94 (09) 2467-2474
  • 13 Shiha G, Ibrahim A, Helmy A. , et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int 2017; 11 (01) 1-30
  • 14 Yin M, Glaser KJ, Talwalkar JA, Chen J, Manduca A, Ehman RL. Hepatic MR elastography: clinical performance in a series of 1377 consecutive examinations. Radiology 2016; 278 (01) 114-124
  • 15 Singh S, Venkatesh SK, Wang Z. , et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 2015; 13 (03) 440-451.e6
  • 16 Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?. J Hepatol 2009; 50 (01) 17-35
  • 17 Rustogi R, Horowitz J, Harmath C. , et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 2012; 35 (06) 1356-1364
  • 18 Srinivasa Babu A, Wells ML, Teytelboym OM. , et al. Elastography in chronic liver disease: modalities, techniques, limitations, and future directions. Radiographics 2016; 36 (07) 1987-2006
  • 19 Barr RG, Ferraioli G, Palmeri ML. , et al. Elastography assessment of liver fibrosis: Society of radiologists in ultrasound consensus conference statement. Radiology 2015; 276 (03) 845-861
  • 20 Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002; 36 (05) (Suppl. 01) S47-S56
  • 21 Huber A, Ebner L, Heverhagen JT, Christe A. State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives. Eur J Radiol Open 2015; 2: 90-100
  • 22 Grant A, Neuberger J. ; British Society of Gastroenterology. Guidelines on the use of liver biopsy in clinical practice. Gut 1999; 45 (Suppl. 04) IV1-IV11
  • 23 Banerjee R, Pavlides M, Tunnicliffe EM. , et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 2014; 60 (01) 69-77
  • 24 Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol 2009; 193 (01) 14-27
  • 25 Wagner M, Corcuera-Solano I, Lo G. , et al. Technical failure of MR elastography examinations of the liver: experience from a large single-center study. Radiology 2017; 284 (02) 401-412
  • 26 Yin M, Talwalkar JA, Glaser KJ. , et al. Dynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease. AJR Am J Roentgenol 2011; 197 (01) 64-70
  • 27 Pepin KM, Chen J, Glaser KJ. , et al. MR elastography derived shear stiffness--a new imaging biomarker for the assessment of early tumor response to chemotherapy. Magn Reson Med 2014; 71 (05) 1834-1840
  • 28 Gordic S, Ayache JB, Kennedy P. , et al. Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy. Abdom Radiol (NY) 2017; 42 (06) 1685-1694
  • 29 Abramson RG, Arlinghaus LR, Dula AN. , et al. MR imaging biomarkers in oncology clinical trials. Magn Reson Imaging Clin N Am 2016; 24 (01) 11-29
  • 30 Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013; 58 (03) 593-608
  • 31 Bhala N, Angulo P, van der Poorten D. , et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 2011; 54 (04) 1208-1216
  • 32 Noureddin M, Lam J, Peterson MR. , et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013; 58 (06) 1930-1940
  • 33 Serai SD, Dillman JR, Trout AT. Proton density fat fraction measurements at 1.5- and 3-T hepatic MR imaging: same-day agreement among readers and across two imager manufacturers. Radiology 2017; 284 (01) 244-254
  • 34 Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011; 259 (03) 749-756
  • 35 Yin M, Glaser KJ, Manduca A. , et al. Distinguishing between hepatic inflammation and fibrosis with MR elastography. Radiology 2017; 284 (03) 694-705
  • 36 Wood JC, Enriquez C, Ghugre N. , et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106 (04) 1460-1465
  • 37 Berdoukas V, Chouliaras G, Moraitis P, Zannikos K, Berdoussi E, Ladis V. The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study. J Cardiovasc Magn Reson 2009; 11: 20
  • 38 Westwood M, Anderson LJ, Firmin DN. , et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003; 18 (01) 33-39
  • 39 Alústiza Echeverría JM, Castiella A, Emparanza JI. Quantification of iron concentration in the liver by MRI. Insights Imaging 2012; 3 (02) 173-180
  • 40 Wahidiyat PA, Liauw F, Sekarsari D, Putriasih SA, Berdoukas V, Pennell DJ. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging. Hematology 2017; 22 (08) 501-507
  • 41 Gandon Y, Olivié D, Guyader D. , et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363 (9406): 357-362